A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma.

Overview of attention for article published in Cancer Discovery, June 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 47 X users

Readers on

mendeley: 37 Mendeley

Summary X

So far, Altmetric has seen 81 X posts from 47 X users, with an upper bound of 155,022 followers.

RT @DrBaileeSliker: @MVossMD presenting today at #ESMO23 with the results of the bispecific antibody volrustomig in ccRCC: activity was dem…

23 Oct 2023

Reply Repost Favourite

RT @DrBaileeSliker: @MVossMD presenting today at #ESMO23 with the results of the bispecific antibody volrustomig in ccRCC: activity was dem…

22 Oct 2023

Reply Repost Favourite

@MVossMD presenting today at #ESMO23 with the results of the bispecific antibody volrustomig in ccRCC: activity was demonstrated in treatment naive disease Check out more related to immunology and immunotherapy in ccRCC with this @CD_AACR paper: https://t

22 Oct 2023

Reply Repost Favourite

RT @RobotRrid: RRIDs were included in the Cancer Discovery paper "A Targetable Myeloid Inflammatory State Governs Di…" (https://t.co/SlO2wd…

13 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 77 additional X posts.